Earnings Release • Feb 26, 2020
Earnings Release
Open in ViewerOpens in native device viewer

at 7 a.m.
t
| Underlying [1] EBITDA PROFIT FY: €2,322m -0.4% -2.8% organic [2] |
Underlying EBITDA was stable over the year, in line with expectations. Positive forex impact offset a modest decrease on an organic [2] basis. Double digit volume growth in Composite Materials, higher pricing in Performance Chemicals and strong focus on cost discipline helped mitigate demand headwinds in the automotive, electronics and oil & gas markets throughout the year. Underlying EBITDA margin maintained at 23% for 2019, reflecting the resilience of Solvay's businesses in a challenging market environment. |
|---|---|
| Advanced Materials €1,143m -9.3% organic [2] FY: |
Strong demand for composites from aerospace customers contributed to delivery of a record performance in 2019, despite an anticipated slowdown in the fourth quarter due to reduced 737MAX build rates. Specialty Polymers significantly impacted by market headwinds, particularly in automotive and electronics; despite headwinds, maintained leading position across all key markets. |
| Advanced Formulations -12% organic [2] FY: €490m |
Resilient performance in coatings, agro, personal care, flavors and fragrances offset by softer mining environment and increasingly challenging conditions in the oil & gas market. Cost measures partly mitigated the impact of lower volumes. |
| Performance Chemicals +10% organic [2] FY: €852m |
In a supportive market environment, higher prices were achieved in soda ash and peroxide leading to a strong full year performance. |
| Underlying EPS [3] from continuing operations FY: €8.02 -4.7% |
Underlying EPS [3] from continuing operations reflects the lower EBITDA, higher depreciation and tax rate, partly offset by lower financial charges following debt optimization measures. |
| FCF to Solvay shareholders [4] CASH from continuing operations FY: €606m +€40m |
Strong free cash flow, driven by the Company's renewed focus on cash and disciplined working capital management. Record total cash generation led to operational deleveraging of net financial debt of |
| total FY: €801m +€76m |
€414 million, and provisions of €157 million. |
| FCF conversion [4] FY: 27.8% +1.8pp |
The free cash flow conversion [4] improvement reflects higher than forecast cash generation. |
| S ROCE RETURN FY: 8.1% -0.1pp |
Stable returns largely reflect sustained investments for future growth. |
| FY dividend €3.75 recommended |
Stable total dividend recommended of €3.75 gross per share. This leads to a final gross dividend of €2.25 payable on May 20, 2020, following the payment of the interim gross dividend of €1.50 per share in January 2020. |
| LOOK 2020 full year outlook |
Solvay expects organic underlying EBITDA growth [2] between 0% and -3% on a year over year basis, free cash flow conversion of 28% and ROCE to be stable around 8%. |
"We delivered record total free cash flow and cash conversion in 2019, allowing us to deleverage substantially. Our focus on customers and costs amid the challenging market backdrop enabled us to achieve stable EBITDA. As we look ahead, we are taking additional efficiency measures to further align our structure to our G.R.O.W. strategy and confront continuing headwinds. Today, we also released our Solvay ONE Planet sustainability goals, which, together with our new Purpose, will enable us to create long-term value for our shareholders in line with our G.R.O.W. strategy."
An analyst call will be held at 13:00 CET, please see: https://www.solvay.com/en/investors/financial-calendar-events-presentations/webcasts-podcasts-presentations
OUT-
The full financial report can be found on: https://www.solvay.com/en/investors/financial-reporting/solvay-earnings
Underlying EBITDA for the year is expected to be flat to modestly down (0% to -3%) organically [2] compared to €2,322 million in 2019, with growth to be back-ended. Against a backdrop of a strong Q1 2019, first quarter 2020 is expected to be down by high single digit as a combined result of the 737MAX production halt, the impact of the COVID-19 virus, and the increasingly challenging oil and gas market.
Key assumptions:
Our G.R.O.W. strategy, outlined in our November 7, 2019 press release, included a realignment of our businesses into three operating segments, each with distinct business mandates. We will:
* All targets on an organic basis and at constant forex and scope.
** Previously €300 to €350 million
ROCE to be stable around 8%.
In 2020, Solvay is accelerating the alignment of its worldwide organization with its G.R.O.W. strategy and is responding to the challenging economic environment, leading to 500 redundancies and 150 new positions to support future growth. The social procedures are launched on February 26 and the savings will commence in the fourth quarter of 2020 and will be fully implemented by the end of 2021. This plan will complement prior measures and raise our mid-term cost reduction target to at least €350 million. Restructuring charges of approximately €70 million will be provisioned in our first quarter financials. It should be noted that, in the fourth quarter of 2019 a provision of €48 million was reversed from the prior program.
| Extra financial indicators | 2019 | 2018 | 2017 |
|---|---|---|---|
| Greenhouse Gas emissions (scope 1 and 2) Evolution yoy (%) |
-5% | flat | |
| Sustainable solutions As % of Group sales |
53% | 50% | 49% |
| Occupational accidents at Group sites * Evolution yoy (%) |
-18% | -17% | -16% |
| Employees involved in societal actions As % of employees |
47% | 33% | 33% |
*Rate of accidents with medical treatment, with or without work stoppage
The -5% reduction in greenhouse gas emissions is primarily the result of investments in cogeneration activities.
More than half of Solvay's portfolio is now solidly positioned as "Sustainable solutions". The progress is the combination of stronger organic growth in sustainable solutions and environmental improvements of operations.
This improving outcome is due to a continued and unrelentless focus on safety.
The Citizen Day - Solvay's first World Citizen Day for environmental preservation - contributed to the significant increase from 33% to 47% of employees involved in societal actions in 2019.
Solvay today announced a new 2030 sustainability program, Solvay ONE Planet, an integral element of the Group's G.R.O.W. strategy that is directly aligned with its purpose of bonding people, ideas and elements to reinvent progress. The plan outlines ten ambitious targets to measure the Group's progress across three key pillars: climate, resources, and better life. To meet these goals, Solvay pledges to reallocate investments to promote sustainability within its portfolio, operations and workplace. Solvay ONE Planet will create long term and shared value for all stakeholders.
| 2030 vs 2018 | ||
|---|---|---|
| Climate | Greenhouse gas emissions Align trajectory with "below 2°C temperature increase" (Paris Agreement) |
26% reduction |
| Coal phase out and no new coal plant Wherever renewable alternatives exist |
Achieve 100% | |
| Biodiversity Reduce negative pressure (terrestrial acidification, water eutrophication, marine eco-toxicity) |
30% reduction | |
| Resources | Sustainable solutions % of Group sales |
Achieve 65% vs 50% |
| Circular economy Sales of products based on renewable or recycled resources (% of Group sales) |
Achieve 15% vs 7% |
|
| Industrial waste Landfill or incinerated without energy recovery |
30% reduction | |
| Water use efficiency Freshwater withdrawal |
25% reduction | |
| Better life | Safety A zero accident policy aiming to protect the safety and security of its employees |
Aim for zero |
| Inclusion & diversity % of women, middle and senior managers |
Parity (by 2035) vs 24% |
|
| Gender equality Solvay is adapting its global policy of 14 weeks maternity leave to 16 weeks and extending it to co-parents employed by the company, regardless of gender |
Extension to 16 weeks (by 2021) |
(in € million)

Fourth quarter net sales were down -5.2%, with forex conversion effects compensating for -6.6% organic [2] growth, as a result of lower volumes.

Full year net sales were stable, supported by positive forex conversion effects. Organically [2], net sales were down -2.2%, with lower volumes being partly compensated by higher prices.


Fourth quarter underlying EBITDA was down -1.0%, and -3.5% organically [2] excluding forex conversion. Positive net pricing effects compensated for lower volumes, while fixed costs were kept stable. The underlying EBITDA margin was slightly up by +0.9pp at 22%.

Full year underlying EBITDA was down -0.4%, and -2.8% organically [2], mostly on lower volumes.

Fourth quarter 2019 underlying earnings per share [3] from continuing operations were down 13% at €1.34, primarily due to higher depreciation and amortization charges, as investments for future growth were sustained.

Full year underlying earnings per share [3] from continuing operations were down -4.7% at €8.02. Higher depreciation and amortization charges and the slightly lower EBITDA were mitigated by lower net financial charges, following the repayment of higher interest-yielding debt in June 2018 and May 2019. Total underlying earnings per share in the full year was modestly down thanks to a higher contribution from the discontinued polyamide operations.

Fourth quarter free cash flow to Solvay shareholders from continuing operations was €261 million. This is lower than the same quarter last year, mainly as a result of improved phasing of working capital, whereas in 2018 the cash inflow was concentrated in the fourth quarter, with €366 million (versus €255 million in the fourth quarter of 2019). Total Free Cash Flow to Solvay shareholders was €274 million.
Full year free cash flow to Solvay shareholders from continuing operations was €606 million, up €40 million year on year. Working capital was positive at €7 million, resulting from more disciplined management.
cont. ops.
Capex from continuing operations increased by +5.4% compared to €794 million in 2018. Provision payments were largely in line with last year, and taxes were up €(29) million, as expected.
Discontinued operations contributed €195 million, €35 million more than in 2018. These operations consist of the Polyamide activities sold on January 31, 2020 to BASF and Domo. As a consequence, total free cash flow to Solvay shareholders amounted to €801 million in 2019.

Underlying net financial debt [7] was €(5.4) billion. Strong operational cash flow of €801 million funded dividends of €387 million as well as an additional voluntary pension contribution of €114 million. Taking into account other factors such as forex and M&A impact, net financial debt was reduced by €152 million and the underlying leverage ratio improved to 2.0x. Solvay called a €0.70 billion hybrid bond at 4.20% in May 2019, which was partly pre-financed by a €0.30 billion hybrid bond at 4.25% issued in November 2018. In September 2019 Solvay also redeemed the outstanding US\$800 million 3.400% notes due 2020, and partly replaced it by the issuance of a €600 million new bond at 0.50% in August. These steps contribute to a reduction in financial charges; full effects will be visible in 2020.

Provisions decreased from €(3.8) billion to €(3.7) billion. Strong operational cash deleveraging of €157 million were supplemented by an additional voluntary pension contribution of €114 million. These largely offset a €231 million increase in post-employment provisions related to the net effect of lower discount rates and higher returns from plan assets.
In 2019, discontinued operations mainly consisted of the more commoditized Performance Polyamides activities to be sold to BASF and Domo Chemicals.
The contribution of discontinued operations to the profit of Solvay amounted to €236 million (+18% compared to 2018).
Free cash flow from discontinued operations in 2019 amounted to €195 million.
The transaction has been completed on January 31, 2020. The transaction is based on an enterprise value of €1.6 billion and the net cash proceeds to be received on the combined transaction are estimated to be around €1.2 billion, subject to customary post-closing purchase price adjustments.
Following the closing of the transaction, the net proceeds have been already partly used to improve the balance sheet. €380 million have been used to voluntarily reduce the pension provisions, on top of the €114 million already paid in the fourth quarter of 2019.

| (in € million) | Q4 2019 | Q4 2018 PF |
% yoy | FY 2019 | FY 2018 PF |
% yoy |
|---|---|---|---|---|---|---|
| Net sales | 1 | 1 | -3.5% | 6 | 7 | -14% |
| EBITDA | (35) | (53) | +34% | (163) | (189) | +14% |
Fourth quarter underlying EBITDA costs were €(35) million, €18 million better than in 2018. Continued focus on cost discipline and lower provisions for bonuses, more than offset inflation.
Corporate & Business Services includes corporate functions, Corporate research & innovation and energy services, whose mission is to optimize energy consumption and reduce CO2 emissions.
Full year underlying EBITDA was €(163) million, €26 million better, reflecting cost reductions and austerity measures, favorable conditions on the energy market and lower provisions for bonuses.

Fourth quarter net sales were down -2.2%, of which -4.1% on an organic [2] basis excluding forex conversion effects. Double-digits volume growth in Composite Materials partly offset the decline in Specialty Polymers. Prices benefited the segment in the quarter.
Fourth quarter underlying EBITDA decreased by -11% and was down -12% organically [2] excluding forex conversion effects, as the price increase could not mitigate lower volume. Costs were also slightly higher, due mainly to inventory destocking in both Specialty Polymers and Composites. Measures to improve production yield and optimize the supply chain partly offset the destocking impact. The underlying EBITDA margin fell 2.2pp to 24%.
Full year net sales increased by +2.9% overall and by +0.3% organically [2]. Lower volumes in Specialty Polymers' automotive and electronics markets were offset by doubledigit growth in Composite Material's for aerospace. Prices were up across the segment.
Full year underlying EBITDA was down -6.7% and -9.3% organically [2]. Higher prices, as well as cost containment and productivity measures only partly offset the higher cost base, resulting primarily from destocking and the effect of expanded production capabilities in Composite Materials. The one-time pension-related synergy benefit of €19 million, booked in the second quarter of 2018, had a -1.5% impact on the 2019 full year EBITDA. The EBITDA margin was down -2.6pp at 25%.
Advanced Materials offers a unique portfolio of highperformance polymers and composite technologies used primarily in sustainable mobility applications. Its solutions enable weight reduction and enhance performance while improving CO2 and energy efficiency. Major markets served include next-generation mobility in automotive and aerospace, healthcare and electronics.

| Q4 2018 | FY 2018 | |||||
|---|---|---|---|---|---|---|
| (in € million) | Q4 2019 | PF | % yoy | FY 2019 | PF | % yoy |
| Net sales | 663 | 764 | -13% | 2,846 | 3,057 | -6.9% |
| EBITDA | 102 | 122 | -17% | 490 | 533 | -8.1% |
| EBITDA margin | 15.4% | 16.0% | -0.6pp | 17.2% | 17.4% | -0.2pp |
Fourth quarter net sales were down -13%, and -15% organically [2] as North American shale oil & gas stimulation activities were increasingly challenging.
Fourth quarter underlying EBITDA decreased by -17% and excluding forex conversion effects -19% organically [2] , due to the lower volumes. These were partly compensated by better prices and cost reduction measures. The underlying EBITDA margin of the fourth quarter decreased by 0.6pp at 15.4%.
Full year net sales were down -6.9% and -10% organically [2]. Prices were slightly up, and volumes declined -11% primarily linked to the challenging shale oil & gas conditions in North America and softer activity in mining in the second half. Aroma Performance sales were up on volumes, notably in natural vanillin, and prices.
Full year underlying EBITDA was down -8.1% and -12% organically [2]. The significant volume declines were mitigated by price increases and cost containment measures, particularly in Novecare, leading to stable EBITDA margin of 17%.
Advanced Formulations includes a broad-based portfolio of surface chemistries focused on improving the world's resource efficiency. The segment offers customized formulations that alter fluids behavior to optimize yield while reducing environmental impact. Major markets include resource efficiency in oil & gas, mining and agriculture, as well as consumer goods, and food.

Fourth quarter net sales in the segment were down -1.3%, and -1.5% organically [2]. Higher contract prices for soda ash and peroxides did not fully offset the lower volumes.
Fourth quarter underlying EBITDA rose +15%. Excluding scope and forex conversion effects it grew +14%, mainly due to higher prices for soda ash and peroxides as well as favorable energy costs and productivity gains across the supply chain. Consequently, the segment EBITDA margin grew +4.1pp to 29%.
Full year net sales in the segment were up +2.5% and +2.2% organically [2], reflecting the higher contract prices for soda ash and peroxides, and more than offsetting lower sales in Coatis, which compare to a very strong 2018.
Full year underlying EBITDA grew +12% and +10% organically [2] driven by higher prices. Productivity gains, favorable energy costs and a strong contribution from the Russian PVC joint venture also contributed positively to the performance. A one-time gain of €12 million was booked in the second quarter on the settlement of an energy contract in the soda ash business. The EBITDA margin was up +2.5pp at 30%.
Performance Chemicals hosts chemical intermediate businesses focused on mature and resilient markets. Solvay is a world leader in soda ash and peroxides and major markets served include building and construction, consumer goods and food. It provides resilient profitability thanks to good pricing and market dynamics, underpinned by high quality assets.
| Q4 2018 | FY 2018 | |||||
|---|---|---|---|---|---|---|
| (in € million) | Q4 2019 | PF | % yoy | FY 2019 | PF | % yoy |
| Net sales | 2,440 | 2,574 | -5.2% | 10,244 | 10,257 | -0.1% |
| EBITDA | 525 | 531 | -1.0% | 2,322 | 2,330 | -0.4% |
| EBITDA margin | 21.5% | 20.6% | +0.9pp | 22.7% | 22.7% | -0.1pp |
| EBIT | 306 | 325 | -5.7% | 1,503 | 1,554 | -3.2% |
| Net financial charges [6] | (86) | (82) | -4.2% | (332) | (342) | +2.8% |
| Income tax expenses | (74) | (73) | -1.5% | (305) | (303) | -0.6% |
| Tax rate | 27.8% | 26.1% | +1.6pp | |||
| Profit from discontinued operations | 24 | 47 | -49% | 247 | 216 | +14% |
| (Profit) / loss attributable to non-controlling interests | (8) | (10) | -18% | (39) | (40) | -2.5% |
| Profit / (loss) attributable to Solvay shareholders | 163 | 208 | -21% | 1,075 | 1,085 | -1.0% |
| Basic earnings per share (in €) | 1.58 | 2.01 | -21% | 10.41 | 10.51 | -0.9% |
| of which from continuing operations | 1.34 | 1.55 | -13% | 8.02 | 8.42 | -4.7% |
| Capex in continuing operations | (255) | (243) | -4.9% | (826) | (794) | -4.0% |
| FCF to Solvay shareholders from continuing operations | 261 | 438 | -40% | 606 | 566 | +7.1% |
| FCF to Solvay shareholders | 274 | 454 | -40% | 801 | 726 | +10% |
| FCF conversion ratio | 56% | 89% | -32% | 28% | 26% | +1.8% |
| Net financial debt [7] | (5,386) | (5,386) | ||||
| Underlying leverage ratio [8] | 2.0 | 2.0 | ||||
| CFROI | 6.5% | 6.8% | -0.3pp | |||
| ROCE | 8.1% | 8.2% | -0.1pp | |||
| Research & innovation | (336) | (352) | +4.7% | |||
| Research & innovation intensity | 3.3% | 3.4% | -0.2pp |
All comparisons are made year on year with 2018 pro forma figures, as if IFRS 16 had already been implemented in 2018, unless stated otherwise.
| ംഎ Financial review | ||
|---|---|---|
| FY consolidated income statement | FY 2019 | FY 2018 PF | ||||
|---|---|---|---|---|---|---|
| Adjust | Under | Adjust | Under | |||
| (in € million) | IFRS | ments | lying | IFRS | ments | lying |
| Sales | 11,227 | - | 11,227 | 11,299 | - | 11,299 |
| of which revenues from non-core activities | 983 | - | 983 | 1,042 | - | 1,042 |
| of which net sales | 10,244 | - | 10,244 | 10,257 | - | 10,257 |
| Cost of goods sold | (8,244) | 2 | (8,242) | (8,258) | 2 | (8,256) |
| Gross margin | 2,983 | 2 | 2,985 | 3,042 | 2 | 3,043 |
| Commercial costs | (381) | - | (381) | (373) | - | (373) |
| Administrative costs | (950) | 28 | (922) | (1,005) | 35 | (970) |
| Research & development costs | (323) | 3 | (321) | (297) | 3 | (294) |
| Other operating gains & losses | (131) | 182 | 51 | (123) | 197 | 74 |
| Earnings from associates & joint ventures | 95 | (3) | 92 | 44 | 30 | 74 |
| Result from portfolio management & reassessments | (914) | 914 | - | (208) | 208 | - |
| Result from legacy remediation & major litigations | (61) | 61 | - | (86) | 86 | - |
| EBITDA | 2,222 | 99 | 2,322 | 2,030 | 301 | 2,330 |
| Depreciation, amortization & impairments | (1,906) | 1,087 | (818) | (1,036) | 260 | (777) |
| EBIT | 316 | 1,187 | 1,503 | 994 | 560 | 1,554 |
| Net cost of borrowings | (141) | 13 | (128) | (134) | - | (134) |
| Coupons on perpetual hybrid bonds | - | (105) | (105) | - | (112) | (112) |
| Interests and realized foreign exchange gains (losses) on the RusVinyl joint venture |
- | (18) | (18) | - | (21) | (21) |
| Cost of discounting provisions | (105) | 20 | (85) | (77) | 3 | (74) |
| Result from equity instruments measured at fair value through other comprehensive income |
4 | - | 4 | - | - | - |
| Profit / (loss) for the period before taxes | 74 | 1,097 | 1,171 | 783 | 429 | 1,212 |
| Income taxes | (153) | (151) | (305) | (73) | (230) | (303) |
| Profit / (loss) for the period from continuing operations | (79) | 946 | 866 | 710 | 199 | 909 |
| Profit / (loss) for the period from discontinued operations | 236 | 11 | 247 | 201 | 15 | 216 |
| Profit / (loss) for the period | 157 | 957 | 1,113 | 910 | 215 | 1,125 |
| attributable to Solvay shareholders | 118 | 956 | 1,075 | 871 | 214 | 1,085 |
| attributable to non-controlling interests | 38 | 1 | 39 | 39 | - | 40 |
| Basic earnings per share (in €) | 1.15 | 9.27 | 10.41 | 8.43 | 2.08 | 10.51 |
| of which from continuing operations | (1.14) | 9.16 | 8.02 | 6.49 | 1.93 | 8.42 |
| Diluted earnings per share (in €) | 1.15 | 9.25 | 10.39 | 8.40 | 2.07 | 10.46 |
| of which from continuing operations | (1.14) | 9.14 | 8.01 | 6.46 | 1.92 | 8.38 |
IFRS profit attributable to Solvay share was €118 million, €(957) million lower than the underlying profit. The adjustments to IFRS results were made primarily for the following elements:

Geoffroy d'Oultremont +32 2 264 2997
Bisser Alexandrov +32 2 264 3687

Relations
Geoffroy Raskin +32 2 264 1540 [email protected]
Nathalie van Ypersele +32 478 20 10 62 [email protected] Brian Carroll +32 2 264 15 30 [email protected]
Jodi Allen +1 609 860 4608 [email protected]

Media relations
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end-markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its lightweighting materials promote cleaner mobility, its formulations optimize the use of resources, and its performance chemicals improve air and water quality.
Solvay is headquartered in Brussels with around 24,100 employees in 64 countries. Net sales were €10.2 billion in 2019, with the vast majority of activities where Solvay ranks among the world's top 3 leaders, resulting in an EBITDA margin of 23%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris Bloomberg: SOLB.BB - Reuters: SOLB.BR), and in the United States its shares (SOLVY) are traded through a level-1 ADR program. (Figures take into account the planned divestment of Polyamides.)
Solvay SA/NV
Rue de Ransbeekstraat 310 B1120 Brussels Belgium T: +32 2 264 2111 F: +32 2 264 3061

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.